ประเทศ: ไอร์แลนด์
ภาษา: อังกฤษ
แหล่งที่มา: HPRA (Health Products Regulatory Authority)
Rosuvastatin
Actavis Group PTC ehf
C10AA; C10AA07
Rosuvastatin
10 milligram(s)
Film-coated tablet
Product subject to prescription which may be renewed (B)
HMG CoA reductase inhibitors; rosuvastatin
Marketed
2010-11-26
1/9 PACKAGE LEAFLET: INFORMATION FOR THE USER ROSUVASTATIN ACTAVIS 5MG FILM-COATED TABLETS, ROSUVASTATIN ACTAVIS 10 MG FILM-COATED TABLETS, ROSUVASTATIN ACTAVIS 20 MG FILM-COATED TABLETS, ROSUVASTATIN ACTAVIS 40 MG FILM-COATED TABLETS _ Rosuvastatin (as Rosuvastatin calcium) _ READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. Keep this leaflet. You may need to read it again. If you have any further questions, ask your doctor or pharmacist. This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours. If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4. WHAT IS IN THIS LEAFLET: 1. What Rosuvastatin Actavis is and what it is used for 2. What you need to know before you take Rosuvastatin Actavis 3. How to take Rosuvastatin Actavis 4. Possible side effects 5. How to store Rosuvastatin Actavis 6. Contents of the pack and other information 1. WHAT ROSUVASTATIN ACTAVIS IS AND WHAT IT IS USED FOR Rosuvastatin Actavis belongs to a group of medicines called statins. You have been prescribed Rosuvastatin Actavis because: You have a high cholesterol level. This means you are at risk from a heart attack or stroke. You have been advised to take a statin, because changing your diet and taking more exercise were not enough to correct your cholesterol levels. You should continue with your cholesterol-lowering diet and exercise while you are taking Rosuvastatin Actavis]. Or You have other factors that increase your risk of having a heart attack, stroke or related health problems. Heart attack, stroke and other problems can be caused by a disease called atherosclerosis. Atherosclerosis is due to build up of fatty deposits in your arteries. Why it is important to keep taking Rosuvastatin Actavis Rosuvastatin Actavis is used to correct the levels of fatty subs อ่านเอกสารฉบับเต็ม
Health Products Regulatory Authority 22 November 2019 CRN0090X0 Page 1 of 13 SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Rosuvastatin Actavis 10 mg film-coated tablets 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each tablet contains 10 mg Rosuvastatin (as Rosuvastatin calcium). Each tablet contains 91.440 mg lactose monohydrate. For the full list of excipients see Section 6.1. 3 PHARMACEUTICAL FORM Film-coated tablet. Tablets are round, biconvex, light pink coloured tablets, debossed with "10" on one side. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS TREATMENT OF HYPERCHOLESTEROLAEMIA Adults, adolescents and children aged 10 years or older with primary hypercholesterolaemia (type IIa including heterozygous familial hypercholesterolaemia) or mixed dyslipidaemia (type IIb) as an adjunct to diet when response to diet and other non-pharmacological treatments (e.g. exercise, weight reduction) is inadequate. Homozygous familial hypercholesterolaemia as an adjunct to diet and other lipid lowering treatments (e.g. LDL apheresis) or if such treatments are not appropriate. PREVENTION OF CARDIOVASCULAR EVENTS Prevention of major cardiovascular events in patients who are estimated to have a high risk for a first cardiovascular event (see Section 5.1), as an adjunct to correction of other risk factors. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION Before treatment initiation the patient should be placed on a standard cholesterol-lowering diet that should continue during treatment. The dose should be individualised according to the goal of therapy and patient response, using current consensus guidelines. Rosuvastatin actavis may be given at any time of day, with or without food. TREATMENT OF HYPERCHOLESTEROLAEMIA The recommended start dose is 5 or 10 mg orally once daily in both statin naïve or patients switched from another HMG CoA reductase inhibitor. The choice of start dose should take into account the individual patient's cholesterol level and future cardiovascular risk as well as the potential ri อ่านเอกสารฉบับเต็ม